People were looking for the 96 & 98% validation, but perhaps, that wasn't even what the BD validation was about to begin with. Shouldn't that have been made clearer to us?
Perhaps. But no matter how clear, no matter how frequent the PR's, there would still be 'reading into' and reasonable....or unreasonable.... inferences.
Did any PR intimate that BD would actually JV 'partner' with AMBS upon release of LymPro assay results, or shortly thereafter? Nope.
Yet people said 'connect the dots' and set the expectation...thus far unrealized.
Same thing with the pharm co name dropping and the speculations about the implications of NDA's and of course the 'free range', ever popular, 'something's up'.
I get that everyone WANTS all of that to be true.
Do those of you who post seemingly harmless 'speculations' connect any of those to the short term trading and the flipping on the part of investors who bought into what you posted?
I slam some of you for all of the above described phenomena, but the good news is that all of it it makes for a tradeable stock.
I've learned to discipline myself to 'dip my beak' with small sales upon news. Now I have some powder with which to average down.
I'm pretty sure many of you have learned to do the same.